Here's what Viewray has to say about the situation
October 12, 2023
Dear MRIdian Customer,
The purpose of this letter is to act as a follow up reminder to the official notice of discontinuance for the MRIdian system October 25, 2023. ViewRay was unable to secure a financial partner or a purchaser and will cease all operations as of that date. This includes all quality, regulatory, software support, service support, parts, upgrades, installations, and clinical research services.
We have communicated our plan to discontinue and no longer manufacture or support the MRIdian system to all applicable regulatory agencies. If you decide to continue to use your MRIdian system after the wind-down period, please consult with your local medical device regulations for guidance on safe and compliant use of a non-supported medical device. Also, please be aware, as of the date of this letter, no third party has been authorized to service or support the MRIdian system. Any predatory claims by a third party asserting that they have the rights to service the MRIdian or otherwise have intellectual property rights, are simply false, misleading, and not productive.
ViewRay will publish on the Customer Portal the following items by October 13, 2023, and customers are encouraged to download a local copy as it may likely be unavailable after October 25, 2023:
- MRIdian service manual with instructions for key repairs
- MRIdian preventative maintenance manual and check sheets
- Instructions to de-energizing the magnets
- Instructions to monitor and maintain the magnets
- List of critical components, service tools, and vendor contact information
- Service qualifications and a list of individuals who are qualified to perform service activities on MRIdian
As a reminder this information is available for your internal use only and none of the information contained, is to be reproduced, distributed, used or disclosed, either in whole or in part, except as specifically authorized by ViewRay or upon Chapter 7, the US trustee.
If you are having problems obtaining access to the Customer Portal, please contact for support:
[email protected]
Those customers wishing to continue their programs past October 25, 2023, are reminded of the following:
- Part availability is not guaranteed from vendors
- Software support from ViewRay will not be available
- ViewRay designed service tools will not be available
- Any modification to the Bill of Materials likely has regulatory consequences. Please consult with your local medical device regulations for guidance.
It’s incredibly unfortunate that a restructuring path was not successful for ViewRay. This will be my last official customer communication as we prepare to cease operations and convert to Chapter 7. We appreciate the support you have shown and the lifesaving treatments you have provided with MRIdian.
If you have any further questions, please contact the head of customer service, Martin Cleaton at
[email protected].
Sincerely,
Paul Ziegler President and CEO ViewRay, Inc.